Publications by authors named "Raimundo Cervera"

Article Synopsis
  • * The study identified AXL overexpression as a crucial factor in resistance to trastuzumab, which activates specific pathways that reduce treatment effectiveness.
  • * Targeting AXL, either through genetic modifications or inhibitors, restored sensitivity to trastuzumab and could serve as a prognostic biomarker in HER2-positive breast cancer patients.
View Article and Find Full Text PDF

Breast cancer is the most frequent cancer in women worldwide. Despite the improvement in diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain higher than desirable. Alterations in microRNAs have been linked to changes in critical processes related to cancer development and progression.

View Article and Find Full Text PDF